Coherent Diagnostic Technology, a developer of optical coherence tomography (OCT) systems for medical imaging applications, is changing its name to LightLab Imaging. Paul Magnin, president and CEO of LightLab, said his company predicts that light will
Coherent Diagnostic Technology, a developer of optical coherence tomography (OCT) systems for medical imaging applications, is changing its name to LightLab Imaging. Paul Magnin, president and CEO of LightLab, said his company predicts that light will have an important role in imaging and medicine, and the new name better captures this movement.
Systems using OCT have already been deployed for use in ophthalmic applications (SCAN 9/1/99). The FDA is reviewing several LightLab Imaging products using OCT for market clearance. In addition, the company has products in the pipeline that it will submit to the FDA in the near future, according to a company spokesperson.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.